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We investigated the estrogenic activity of various environmental pollutants (xenobiotics), in
particular the xenoestrogen o,p-DDT, and compared their effects with those of endogenous
estrogens, phytoestrogens, and mycoestrogens on estrogen receptor binding capacity, induction
of estrogen end products, and activation of cell proliferation in estrogen-sensitive human breast
cancer cells in monolayer culture. We also quantified the levels of phytoestrogens in extracts of
some common foods, herbs, and spices and in human saliva following consumption of a high
phytoestrogen food source (soy milk) to compare phytoestrogen abundance and bioavailability
relative to the reported xenoestrogen burden in humans. Results show that natural endogenous
estrogens, phytoestrogens, mycoestrogens, and xenoestrogens bind estrogen receptor (ER) in
intact cells, but demonstrate marked differences in their ability to induce end products of
estrogen action and to regulate cell proliferation. All of the different classes of estrogens
stimulated cell proliferation at concentrations that half-saturated ER, but only some classes were
able to induce estrogen-regulated end products. Genistein, a common phytoestrogen found in
soy foods, differed from the xenoestrogen DDT in its effects on cell proliferation and ability to
induce estrogen-regulated end products. Moreover, we found that many of the foods, herbs, and
spices commonly consumed by humans contain significant amounts of phytoestrogens, and
consumption of soy milk, a phytoestrogen-rich food, markedly increases the levels of
phytoestrogens in saliva. In conclusion, our in vitro results predict that a diet high in
phytoestrogens would significantly reduce the binding of weak xenoestrogens to ER in target
tissues in vivo. Environ Health Perspect 105(Suppl 3):637-645 (1997)
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breast cancer, reproduction
Introduction
Each year billions ofpounds ofpesticides,
herbicides, solvents, detergents, and other
chemical wastes spill into our ecosystem and
accumulate in the air, water, and, food chain
(1,2). Environmental scientists have recently
raised concern that many ofthese industrial
wastes are weakly estrogenic and, by acting
as estrogen mimics (xenoestrogens), disrupt
normal endocrine function, leading to repro-
ductive failure and cancer ofestrogen-sensi-
tive tissues (1-3). Recent scientific reviews
(4,5) have contested the notion that trace
levels ofpetrochemicals towhich humans are
inadvertently exposed act as endocrine dis-
ruptors or increase the incidence ofcancer.
This counterargument suggests that xeno-
estrogen levels to which humans are exposed
daily are trivial relative to the daily exposure
to natural phytoestrogens found abundantly
in common foods consumed byhumans.
Many estrogen mimics are produced
by plants and by the petrochemical and
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pharmaceutical industries. These can be
categorized broadly as natural or synthetic
(Table 1). Natural estrogens are those that
humans, and all other animal species, have
been exposed to throughout their evolu-
tion. They are manufactured by the body
(endogenous estrogens), or by plants (phy-
toestrogens), or fungi (mycoestrogens). In
contrast, synthetic estrogens are those that
only recently have been introduced into
the ecosystem either purposely as pharma-
ceuticals (drugs) or inadvertently by the
petrochemical industry (xenoestrogens).
Phytoestrogens are found abundantly in
foods, herbs, and spices commonly con-
sumed by humans (6,7), whereas myco-
estrogens (8) and xenoestrogens (1,2,4) gain
entry into the food chain as contaminants
ofair, water, and food.
The molecular structure of exogenous
natural and synthetic estrogens may be
very similar to, or strikingly different from,
the parent hormone estradiol (4,5,7,9).
Despite their structural diversity, all ofthe
exogenous estrogens, when consumed
either as natural components (phytoestro-
gens) or contaminants (xenoestrogens,
mycoestrogens), have the capacity at some
concentration to bind to estrogen receptors
(ERs) in target cells of the body and
initiate (agonist) or inhibit (antagonist)
estrogenlike actions (10,11). In doing so,
estrogen mimics have the potential to alter,
either in a beneficial or harmful manner,
the growth, development, and function of
estrogen target tissues.
In this study we compared the relative
estrogenic potency ofvarious well-known
environmental petrochemical pollutants
with natural endogenous estrogens, phy-
toestrogens, and mycoestrogens in order to
shed light on possible differences in molec-
ular actions that might account for the
putative harmful effects ofxenoestrogens
on reproductive function and cancer. We
investigated differences in the ability of
these structurally diverse compounds to
bind ER, induce estrogen-regulated end
products, and activate cell proliferation in
well characterized estrogen-sensitive human
breast cancer cell lines in vitro. We also
used an estrogen radioreceptor assay to
quantitate the levels ofphytoestrogens pre-
sent in common foods, herbs, and spices in
order to compare their abundance relative
to the reported burden ofxenoestrogens in
humans (1,2,4,5). In addition, we devel-
oped a saliva radioreceptor assay to monitor
the bioavailable fraction ofphytoestrogens
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Table 1. Classification of natural and synthetic estrogens.
Subtype Source Examples
Natural estrogens
Endogenous estrogens Ovarian, adrenal, adiposetissue Estradiol, estrone, estriol
Exogenous estrogens
Replacement therapy Pharmaceutical Estradiol, estrone, estriol, equilinin
Phytoestrogens Foods, herbs, spices Genistein, coumestrol, equol,
enterolactone
Mycoestrogens Fungi Zearalenol, zearalenone
Synthetic estrogens
Exogenous estrogens
Replacement therapy Pharmaceutical Ethinyl estradiol, diethylstilbestrol
Xenoestrogens Industrial
Pesticides DDT, methoxychlor, dieldrin, kepone
Preservatives BHA, BHT
Solvents Hydrocarbons
Plasticizers Bisphenol-A
Synthetic antiestrogens
Exogenous estrogens
Cancertherapy Pharmaceutical Tamoxifen
Xenoantiestrogen Industrial TCDD (dioxin)
Abbreviations: BHA, butylated hydroxyanisole; BHT, butylated hydroxytoluene.
in the bloodstream following consumption
of phytoestrogen-rich foods, herbs, or
spices. As a paradigm for this system we
measured the total estrogen content of
saliva following consumption ofsoy milk, a
phytoestrogen-rich food source.
Methods
Chemicals, Hormones, andReagents
Propidium iodide, sulforhodamine B, calf
thymus DNA, Triton X-100, thimerosol,
bovine serum albumin (BSA), estradiol,
progesterone, ,-naphthoflavone, hesper-
itin, genistein, equol, and kaempferol were
purchased from Sigma Chemical Co.
(St. Louis, MO). o,p-DDT, o,p-DDE,
hexachlorobenzene (HCB), ,B-hexachloro-
cyclohexane (P-BHC), oxychlordane (OC),
pentachlorobiphenyl (PCB-126), hexachlo-
robiphenyl (PCB-153), and 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) were agift
from D. Hayward (Hazardous Materials
Laboratory, California Department of
Health Services). 4-Hydroxytamoxifen
(ICI 79280) was a gift from Stuart
Pharmaceuticals (Wilmington, DE).
Cells andCulture Conditions
ER positive MCF-7 and T47D breast
carcinoma cell lines were purchased
from American Type Culture Collection
(Rockville, MD). The breast cancer cell
lines were grown and passaged routinely as
monolayer cultures in T-25 flasks in
RPMI-1640 medium (Sigma R-7880) with
5% fetal bovine serum (FBS; Hyclone A-
1115) containing 0.2 ng/ml insulin (Sigma
I-2767) at 37°C in 5% CO2.
CellProliferation Studies
For growth studies, cells were removed
from their growth chamber with trypsin/
EDTA (Sigma T-5775), counted, diluted
to 8000 to 20,000 cells/ml in growth media
and 250 pl seeded into 96-well tissue cul-
ture plates. Twenty-four to 48 hr after cell
plating, mediawas completely removed and
cells were switched to 250-pl well ofphe-
nol-red-free RPMI-1640 medium (Sigma
R-8632) containing 1 to 2% charcoal-
treated FBS (CT-FRI) (Hyclone A-1120)
(1% CT-FRI) and insulin, as above, with
or without test compounds in a final
ethanol concentration of0.1%. Controls
contained 0.1% ethanol. For growth
studies, media was changed after the first 4
days, then every 2 days thereafter.
Hormone-treated cells (in triplicate)
were allowed to reach near confluence, for-
malin-fixed in situ with 10% formalde-
hyde/phosphate-buffered saline (PBS) for
15 min at room temperature, and then
analyzed in situ for DNA and total cellular
protein as previously described (12).
EstrgenRecptorBindingAssay
Preparation ofTest Compounds. Test
compounds wereprepared in 100% ethanol
as 100Ox stocks ranging from 1 nM to 10
mM. For the assay, stock solutions were
diluted 250-fold in 1% CT-FRI. Control
tubes contained 1% CT-FRI with 0.4%
ethanol; final concentration in the incuba-
tion was 0.1%. Duplicate 50-pl aliquots
of test compounds were delivered into
12 x75 mm glass tubes followed by 50 ,ul
of125I-170i-estradiol (E2) (NEX-144, 2200
Ci/mmol, NEN-Dupont, Wilmington,
DE) diluted in 1% CT-FRI to a concentra-
tion of 0.4 nM. The tubes were equili-
brated in the cell culture incubator at 370C
in 5% CO2 while the cells were prepared.
Preparation ofCells. MCF-7 cells
were fed with 5% CT-FRI at least 3 days
prior to the assay. Cells were removed with
trypsin/EDTA and, after dispersion to
single cells, diluted in 1% CT-FRI to 1.75
( 0.5)x 106 cells/ml.
Assay Proper. Diluted cells (100 pl)
were added to tubes containing test com-
pounds and 125I-E2. The contents were
mixed by gently shaking the tube rack and
incubated at 370C with 5% CO2 for 45
min, with gentle mixing every 15 min.
Following incubation, the cells were sedi-
mented at 600xgfor 5 min at 4°C. The
supernatant was removed and the tubes
plunged into an ice-water bath. Within
5 min, 1 ml ofice-cold TPSG (0.2% Triton
X-100 in PBS containing 0.1 M sucrose
and 10% glycerol) was added as described
(12). Tubes were vigorously vortexed then
allowed to incubate 5 min before intact
nuclei were centrifuged for 5 min at 40C.
The supernatant was discarded, and 125I-E2
remaining in the washed nuclei was mea-
sured in a gamma counter. Results are
expressed as percent 125I-E2 binding to ER
in the nucleus in the absence (control =
100%) or presence ofincreasing concentra-
tions oftest compounds.
pS2MeasurementinCell Growth
MediabyRadioimmunoassay
MCF-7 cells were grown in 96-well plates
as previously described in "Culture
Conditions." Approximately 48 to 72 hr
(established as maximal time point for pS2
induction) following addition of250 pi of
the test compounds, 125 pl of growth
media was removed and transferred to a
parallel plate. Sodium azide (10%) was
added to 0.05% final concentration, and
the plate was sealed and stored at 40C until
pS2 could be assayed (usually within
1 week). The remaining 125 il ofgrowth
media covering the cells was discarded.
The cells were then formalin fixed and
assayed for DNA and protein content as
described above. pS2 was measured by a
two-site enzyme-linked immunosorbent
assay format as previously.described (12).
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ImmunocytochemicalAnalysis
ofpS2, Estrogen Receptor, and
Progesterone ReceptorinFormalin-
fixed/Paraffin-embedded Cells
Preparation ofCels. Cells were grown in
T-25 flasks in 5% CT-FRI in the presence
and absence ofchemicals as indicated in the
text. Following incubation for 2 to 3 days,
cells were gently scraped from the flaskwith
a plastic cell rake into the growth media
and transferred to a glass tube. Cells were
washed twice with PBS and centrifuged at
500xg. Cells were fixed overnight at 40C
in 10% formalin/PBS, then dehydrated in
graded ethanol and xylene. The dehydrated
cell pellet was embedded in paraffin, cut
into 5-plm sections, and mounted on glass
slides (Probe-On Plus, Fisher Biotech,
Fisher Scientific, Pittsburgh, PA, 15-188-52)
for immunocytochemical analysis.
Immunocytochemical Analysis. Glass
slide-mounted thin sections were air-dried
overnight and dewaxed with Hemo-DE
(Fisher 15-182-507A) followed by rehydra-
tion in 100 and 95% ethanol and PBSTX
(PBS containing 0.1% Triton X-100 and
0.01% thimerosol). Each treatment was
repeated 5 times for 5 min. The specimen
slides were then treated with 1% hydrogen
peroxide in deionized water (dH2O) for
15 min and washed 5 times with PBSTX.
All treatments were followed by five washes
in PBSTX unless indicated otherwise.
For pS2 analysis, the slides were
incubated with rabbit polyclonal anti-
body to pS2 (Novacastra, Burlingame, CA,
NCL-pS2) at 1/400 dilution in PBS buffer
containing 1% BSA followed by bio-
tinylated antirabbit IgG (H+L, Vector
Laboratories, Burlingame, CA), horse-
radish peroxidase streptavidin (Vector
Laboratories, SA-5004). pS2 was then
revealed in the cells by incubation with the
aminoethylcarbazole peroxidase substrate
(Zymed, San Francisco, CA, 00-2007).
Cells were counterstained with 10% Harris
hematoxylin (Sigma GHS-3-16), washed
with water, covered with Crystal/Mount
(Biomeda, Fisher Scientific) and dried for
20 min at 80°C.
For detection of ER and progesterone
receptor (PR) in formalin-fixed/paraffin-
embedded cells by immunocytochemistry,
slides containing thin sections were treated
as above for pS2 with the exception that
primary antibodies were mouse monoclon-
als (ER, Immunotech, Inc., Westbrook,
ME, 1344; PR, Signet Laboratories, Inc.,
Dedham, MA, 521-26) and the secondary
antibody a biotinylated goat antimouse
IgG (Zymed 62-6540).
Immunocytochemical staining for pS2
(cytoplasmic granular staining) and for ER
and PR (nuclear staining) was evaluated by
light microscopy at 100x and 250x as fol-
lows: none or less than 10% (-), 10-40%
(+), or >40% (++) ofcells staining at any
intensity (weak to strong).
PreparationofHerbal xracts
(IInctures)
Dried herbs were extracted in 50%
ethanol/dH2O (2 g herbs/10 ml) for 2 days
and the insoluble contents sedimented by
centrifugation at 150Oxg for 15 min at
room temperature. The soluble extract
was removed and transferred to a 15-ml
polypropylene tube and stored at 40C.
Unless otherwise indicated, herbal tinc-
tures were combined with 1% CT-FRI
(4 pl extract/ml) to determine their estro-
gen content by estrogen receptor binding
assay (ERBA).
Collection andProcessing
ofSaliva
Before collecting saliva, volunteers rinsed
thoroughly with cool water and chewed
sugar-free gum for about 5 min to stimu-
late saliva flow. Saliva (5 ml) was then col-
lected in polypropylene tubes. Sodium
azide was added to a final concentration of
0.1% and the saliva frozen, thawed, and
clarified by centrifugation at 1500xgfor
10 min. Saliva (1 ml) was extracted twice
with 1 ml of diethylether and the ether
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evaporated to dryness under nitrogen. The
dried ether extract was then reconstituted
in 1.0 ml of0.1% BSA/dH2O and assayed
for estradiol equivalents by the ERBA.
Statistcs
Data are presented as the mean ± SD.
Statistical significance was determined
using the Student's t-test with p< 0.05
evaluated asstatisticallysignificant.
Results
BindingofNatumal andSynthcetic
Compounds toFstrognReceptor
inIntactMCF-7BreastCancerCells
Table 1 compares the ER binding capacity
of several endogenous and exogenous
estrogens. The concentrations ofestradiol,
genistein, zearalenone, and o,p-DDT
required to inhibit the binding ofa single
subsaturating concentration ofradiolabeled
estradiol to ER in intact MCF-7 cells are
shown in Figure 1. The concentration of
these and other endogenous and exogenous
natural and synthetic estrogens and anti-
estrogens required to reduce the binding of
125I-170-estradiol to ER by halfis summa-
rized in Table 2, and expressed relative to
estradiol (100%). The endogenous estro-
gen metabolites 16a-hydroxyestrone and
2-hydroxyestradiol were 20 and 0.1%
as potent as estradiol. The most potent
natural exogenous estrogens tested were
the mycoestrogens zearalenone and its
-13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3
LoglO molar concentration
Figure 1. Competition of natural and synthetic estrogens for[1251]-E2 binding to nuclei of intact MCF-7 cells. Cells
were incubated with [12511-17P-estradiol and increasing concentrations of the test compounds as described in
"Methods." Nuclear radioactivity was determined and results expressed as percent [1251]-E2 binding to ER in the
presence oftestcompounds. Results are representative of at leasttwo other experiments.
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Table 2. Relative binding affinity of natural and synthetic estrogens and antiestrogens to estrogen receptor in
intact MCF-7 cells.
RBA HSC, nM IVC, nM PR-CR/d, mg Reference
Endogenous estrogens
Estradiol 100.0 0.2 0.2-1 0.2-1 (48)
166a-Hydroxyestrone 20.0 1.0 ? NA (36,37)
2-Hydroxyestradiol 0.1 200.0 ? NA (36)
Exogenous antiestrogens
Tamoxifen 0.1 200.0 100-1000 10-30 (49)
4-Hydroxytamoxifen 1.0 20.0 10-100 NA (49)
Phytoestrogens/flavonoids
Genistein 0.1 200.0 0-3000 0-50 (14)
Equol 0.1 200.0 <100 NA
Kaempferol 0.012 2000.0 ? 0-1000
Quercetin 0.001 =2x104 <200 0-1000 (50)
)-Naphthoflavone 0.0 NA ?
Hesperitin 0.0 NA ?
Xenoestrogens/xenobiotics
o,p-DDT 0.012 2000.0 2 0.0025 (4)
o,p-DDE 0.005 4000.0 60
HCB 0.0 NA 6
)-BHC 0.0 NA 4 (19,28-30)
PCB-126 0.0 NA 4-20
PCB-153 0.0 NA 0.2-10
OC 0.0 NA 18
TCDD 0.0 NA
Mycoestrogens
Zearalenone 2.0 10.0 ? 0-0.010 (8)
Zearalenol 100.0 0.2 ? NA
Abbreviations: ?, data not available; NA, not applicable. Relative binding affinity (RBA) is based on the concentra-
tion oftest compound required to reduce binding of 0.2 nM 1251-17j-estradiol to ER in nuclei of intact MCF-7 cells.
Nonradioactive estradiol was used as a standard and assigned an RBA value of 100%. Half saturating concentra-
tion (HSC) is the estimated concentration (nM) of the test compound required to half-saturate nuclear ER. In vivo
concentration (IVC) is the approximate concentration (nM) of the test compound in serum of humans. Production
rate consumption rate per day (PR-CR/d) refers to the amount of endogenous (ovarian synthesis/day in a pre-
menopausal woman) or exogenous estrogens consumed daily(mg).
Table 3. Induction of pS2 by natural and environmental estrogens.
ICA
Treatmenttype Concentration, nM FU ± SD Fold inductiona pS2 ER PR
None 0.0 153 ± 11 1.0 - ++ -
Estradiol 0.2 1010 ±70 6.6 + - +
Progesterone 10.0 62 ± 11 0.4 - ++ -
Cortisol 100.0 109±34 0.7 - _ _
Hydroxytamoxifen 10.0 65 ± 7 0.4 - +
Tamoxifen 1,000.0 97 ± 11 0.6 - ++
Zearalenol 0.2 686± 11 4.5 ++ - +
Zearalenone 10.0 554 ±2 3.6 ++ - +
Genistein 200.0 958 ± 101 6.2 ++ - +
Equol 200.0 805 ± 81 5.2 + - -
Kaempferol 1,000.0 738 ± 80 4.8 + - +
Quercetin 10,000.0 0 0
o,p-DDT 1,000.0 106 ± 16 0.7 - - -
aFold induction of pS2 relative to control. Induction of pS2, ER, and PR in MCF-7 cells exposed to various com-
pounds. Cells were exposed for 48 hr to test compounds at the concentrations indicated. Growth media was col-
lected and pS2 determined as described in "Methods." pS2 results are expressed as mean fluorescent units (FU) ±
SD and fold induction relative to untreated cells. pS2, ER, and PR were determined in formalin-fixed, paraffin-
embedded cells by immunocytochemistry (ICA) as indicated in "Methods."
metabolite zearalenol, which were 2 and
100% as potent as estradiol. The isoflavo-
noids genistein and equol were 0.1% as
potent as estradiol, whereas the bioflavo-
noids kaempferol and quercetin were very
weak ER binders, with relative potencies of
0.01 and 0.001%. Neither hesperitin,
which is a 3'-methylated form ofquercetin,
nor naphthoflavone, which has no phenolic
groups, were able to compete with estradiol
binding to ER at concentrations up
to 10 pM.
Of the seven industrial xenobiotics
tested, only o,p-DDT and op-DDE signifi-
cantly competed with estradiol binding to
ER with relative binding affinities similar
to those of bioflavonoids such as kaemp-
ferol and quercetin, or approximately
0.01% lower than that of estradiol. None
of the other xenobiotics tested at single
concentrations of 1 pM were able to com-
pete with estradiol binding to ER and
therefore were not considered for further
testing. Higher concentrations (>1 pM) of
these highly nonpolar xenobiotics were not
tested because most were insoluble in the
low serum (1%) cell growth media used for
the ERBA.
Estrogen EndProduct
InductionbyNatural
andSyntheticEstrogens
In MCF-7 cells, pS2 and PR are estrogen-
regulated proteins (11,13). PR is an intra-
cellular protein localized to the nuclear
compartment whereas pS2 is a secretory
protein, about halfofwhich is released into
the growth medium within 24 to 48 hr. ER
is also sensitive to estrogens and is downreg-
ulated byestrogen exposure (11). Therefore,
the upregulation of pS2 and PR and the
downregulation ofER were used as indices
ofthe estrogenic activity oftest compounds
from each category listed in Table 2. pS2
was measured both as a secreted protein in
the growth media by enzyme immunoassay
(12) and as an intracellular protein by
immunocytochemistry. ER and PR also
were measured semiquantitatively by
immunocytochemistry. Each compound
was tested at a concentration determined to
approximately half-saturate the nuclear ER
binding sites (Figure 1, Table 1).
Results in Table 3 demonstrate that
estradiol, zearalenol, zearalenone, genistein,
equol, and kaempferol significantly
increased both the extracellular and the
intracellular concentration of pS2. These
estrogens also increased the intracellular
immunostaining for PR, and decreased the
immunostaining for ER, consistent with
their actions as estrogen agonists (11). As
might be expected for estrogen antagonists
(12) such as tamoxifen and hydroxy-
tamoxifen and non-ER-binding ligands
such as progesterone and cortisol, there was
no increase in pS2 or PR. Neither o,p-
DDT nor quercetin, at concentrations that
were shown to half-saturate ER, increased
pS2 or PR; however, both of these weak
estrogens downregulated ER.
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Table 4. Estradiol equivalents (pg)/2 g dry herb or
200 cc soy milk.
Estradiol equivalents Micrograms
Soy milk 8/200 Cc
Licorice 4/2 g capsule
Clover(red) 3
Mandrake 3
Bloodroot 2
Thyme 2
Yucca 0.75
Tumeric 0.5
Hops 0.5
Verbena 0.5
Yellow dock 0.5
Sheep sorrel 0.5
o.oo
0.0 10 pM lOOpM 1 nM 10M n 0M 100M M10 gm 100 ,uM
Molar concentration
Figure 2. Effects of natural and synthetic estrogens on proliferation of ER-positive T47D human breast cancer
cells. Cells were exposed to different concentrations of estrogens for 11 days (Figure 3). The effects of test com-
pounds on cell growth were evaluated by measuring the DNA content of cells in situ as described in "Methods."
Results are expressed as micrograms of DNA per well (mean ± SD) and are representative of at least two other
experiments.
Effect ofNatural andSynthetic
Estrogens on Cell Proliferation
The effects of DDT, estradiol, and several
phytoestrogens on cell proliferation of the
ER(+) human breast cancer cell line T47D,
are shown in Figure 2. The initial concentra-
tions for each test compound were one log
lower than the concentrations determined
in Table 2 to half-saturate ER. Estradiol
was not tested above 10 nM because higher
concentrations are not relevant to expected
in vivo exposure in humans (8).
Cell growth, measured as DNA or total
cellular protein concentration (protein data
not shown), increased with all ER-binding
compounds tested. With some estrogens
(genistein and kaempferol) the response was
biphasic and resulted in stimulation at ER-
saturating doses (1 and 10 pM, respectively),
but abrupt growth inhibition at a slightly
higher concentration (20 pM). In contrast,
other ER-binding compounds (DDT,
equol), although they showed similar
growth stimulation at concentrations that
approximately half-saturated ER (i.e., 1 and
10 FM, respectively), continued to stimulate
growth at higher concentrations (10-20
pM). When hydroxytamoxifen at 100 nM
was combined with ER-saturating doses of
1 nM estradiol and 1 pM equol, genistein,
and DDT, the growth stimulation seen
with these compounds was inhibited to
near control levels (respectively, 0.24 ±0.04,
0.31±0.03, 0.46±0.07, and 0.17±0.05 pg
DNA/well), indicating that the actions of
all ofthese estrogens were ER mediated.
Estrogenic ContentofCommon
Foods, Herbs, andSpices
Nature produces a broad array ofphyto-
estrogens in foods, herbs, and spices
commonly consumed by humans (6,7,
14,15). These phytoestrogens might be
expected to compete with endogenous
estrogens, as well as exogenous xenoestro-
gens, for binding to ER sites in target cells.
To provide some appreciation for the
abundance ofnatural phytoestrogens, rela-
tive to the reported burden of xenoestro-
gens in blood and adipose tissue ofhumans
(1,2,4,5), we used the ERBA to quantify
the phytoestrogen content in extracts of
several foods, herbs, and spices commonly
consumed by humans.
Our laboratory has tested over 200
foods, herbs, and spices for estrogen con-
tent (DT Zava, unpublished data); 12 with
the highest ER-binding activity are listed in
Table 4. Not unexpectedly, soy milk, which
is known to contain high levels ofthe phy-
toestrogens genistein and daidzein (14),
had the highest level of phytoestrogens.
Licorice, Glycyrrhiza glabra, and red clover,
Trifolium pratense, both ofwhich, like soy-
beans, belong to the Leguminosae family,
also contained high levels ofphytoestro-
gens, as reported previously (6). Thyme,
Thymus vulgaris, and tumeric, Curcuma
longa, common spices in foods, and hops,
Humulus lupulus, used in beer production,
were also relatively high in phytoestro-
gens. Other herbs used as phytomedicines
(15,16), such as mandrake, Podophylum
peltatum, bloodroot, Sanguinaria canaden-
sis, verbena, Verbena hastata, yellow dock,
Rumex crispus, and sheep sorrel, Rumex
acetosella, also contained significant levels
ofphytoestrogens.
Use ofSaliva to Measure in Vivo
BioavailailityandEstrogenic
ContentofExogenousEstrogens
In vivo, endogenous and exogenous natural
and synthetic estrogens are constantly
competing for the same ER sites in target
cells. Access to ER will depend on the
estrogen's abundance, affinity, and bio-
availability to target cells (4,5). Saliva is a
natural ultrafiltrate ofblood and has been
shown to contain the bioavailable or free
fraction ofnonpolar, low molecular weight
molecules such as steroid hormones (17,18).
Xenobiotics, as well as phytoestrogens, fall
into this class of low molecular weight,
nonpolar molecules (7,9,16), and are
detectable in saliva. To confirm that the
saliva assay can detect an increase in the
levels ofER-binding components following
consumption of a phytoestrogen food
source, we measured estradiol and total
estrogen levels in saliva after ingestion of
soy milk, which contains high levels of
phytoestrogens (Figure 3A-D).
Four laboratoryvolunteers drank 200 cc
of soy milk, then collected saliva at hourly
intervals over 24 hr. The volunteers refrained
from consumption ofother soy foods over
this time course, but otherwise ate as usual.
Saliva was extracted, reconstituted, then
analyzed for estradiol by conventional
radioimmunoassay and for total estrogens
by ERBA. In three of four individuals soy
milk ingestion resulted in a rapid increase
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Figure 3. Saliva estrogens following soy milk consumption. Volunteers drank 200 cc of soy milk and collected
saliva samples at hourly intervals over 24 hr. Saliva was processed and assayed for ER-binding components by the
ERBA and for estradiol by conventional radioimmunoassay as described in "Methods."
in total salivary estrogens within 1 hr,
followed by a rapid decline over 5 hr. In
several individuals a second peak was seen
at 5 to 12 hr, followed by a return to base-
line within 24 hr. Note that very low levels
ofsalivary estrogens were seen in one indi-
vidual (Figure 3B) following soy milk con-
sumption. Salivary estradiol was also
quantified in the same saliva samples and
did not change significantly over the 24-hr
time course. No changes in total salivary
estrogens were seen over the same time
course when volunteers drank water or
cow's milk (data not shown).
Discussion
In regions where wildlife has been heavily
exposed to industrial pollutants, reproduc-
tive tract failures are commonplace, threat-
ening survival of many animal species
(1,2,9,19,20). These forewarnings have led
environmental scientists to conjecture that
the bioaccumulation ofpetrochemical pol-
lutants with estrogenlike activity in our eco-
system and food chain could also account
for the reported increase in reproductive
dysfunction (3), lower intelligence and
behavioral disorders in children (21,22),
and cancers ofthe breast and reproductive
organs (23-25). This argument has been
refuted (4,5) on the grounds that natural
phytoestrogens, which bind with much
higher affinity to ER, and are consumed in
much higher quantities in common foods
than are xenoestrogens, would diminish
xenoestrogen binding to ER in target
cells to insignificant levels. Hence, by com-
petitively inhibiting xenoestrogen binding
to ER, phytoestrogens in food would sup-
press any toxic effects ofxenoestrogens as
endocrine disruptors or cancer promoters.
The dailyexposure from xenoestrogenic
pesticides such as DDT, dieldrin, endosul-
fan, and methoxychlor is approximately
2.5 pg/day (4,5). The serum concentration
of DDT in women ranges from 2 to 15
nM, which is approximately 5 to 40 ppb
(23-26). Our in vitro cell culture results
(Table 2) demonstrate that the concentra-
tion of DDT required to half-saturate ER
is about 1000-fold higher (1 pM) than the
reported levels ofDDT in serum (23-26).
Based on this information we would not
predict that DDT, or other xenoestrogens
with similar binding affinities to ER,
would have significant estrogenic impact
on target tissues in vivo. However, xeno-
estrogens and other xenobiotics are very
nonpolar molecules and resist metabolic
activation/elimination, which allows them
to bioaccumulate and persist in fatty tissues
of the body for years (23-27). In fact, the
tissue burden of DDT (2 ppm) and other
xenobiotics such as PCBs (5-6 ppm) in
adipose breast tissue ofhumans is nearly
1000-fold higher than their serum levels
(23-27). This biomagnification ofxeno-
estrogens in fatty tissues or organs of the
body could effectively raise the local con-
centrations ofxenoestrogens such as DDT
to the low micromolar range, which could
have estrogenic effects on target tissues,
according to our data (Table 2, Figure 2).
Because xenobiotics bioaccumulate in
fatty tissues of the body over a lifetime,
most currently available assays that assess
the short-term estrogenicity ofa xenobiotic
in animals in vivo, or in human cells in cul-
ture in vitro, probably fall short ofportray-
ing the true estrogenic potential of an
environmental pollutant in humans in
vivo. Moreover, a recent study found that
the cumulative effects ofseveral pesticides
commonly found as pollutants in the envi-
ronment at low levels are over 1000 times
more potent as xenoestrogens than the
individual molecules.
It has been suggested (4,5) that xeno-
estrogens would not be expected to have a
significant impact on estrogen target tissues
because their effects would be competi-
tively blocked from ER sites by the much
higher concentrations of phytoestrogens
consumed in foods. Indeed, our results
confirm that the amounts ofphytoestro-
gens consumed in common foods, herbs,
and spices (Table 4, Figure 3) would be
much greater than the estimated daily
exposure to xenoestrogens (e.g., DDT) and
other xenobiotics found in the air, water,
and food chain (4,5). Moderate consump-
tion ofsoy foods in amounts common to
Asian diets (12,14) results in intake of
about 10 to 20 mg ofphytoestrogens such
as genistein and daidzein (14,29). Based
on the results presented in Figure 3, the
bioavailable levels ofestrogens increase from
less than 50 to about 200 to 1000 pg/ml
following soy milk consumption. From
this we estimate that the bioavailable level
ofphytoestrogens would range from 200 to
1000 ng/ml, or 1 to 3 pM. Hence, the
phytoestrogen concentration after con-
sumption of a soy meal might be expected
to be at least 100 times the reported serum
concentrations ofxenoestrogens (i.e., 1-3
pM vs 2-15 nM). Since the phytoestrogens
bind to ER with about 10-fold greater
affinity than DDT and other xenoestrogens
[(7,9,30); Table 2], this would reduce the
apparent binding ofxenoestrogens such as
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DDT to ER nearly 1000-fold. Other
common spices (e.g., turmeric and thyme)
and hops, which are used copiously in
many foods and beverages (e.g., beer)
could also significantly contribute to the
phytoestrogen content in vivo (Table 4).
Although our in vitro results concur
with Safe's hypothesis (4,5) that the estro-
genic actions of xenoestrogens in vivo
would be expected to be insignificant rela-
tive to endogenous estrogens and dietary
phytoestrogens, it is important to under-
score that significant differences in the
bioaccumulation and metabolism ofxeno-
estrogens in vivo may significantly increase
their biological impact on estrogen target
tissues. As mentioned, the tissue burden of
DDT and other xenobiotics such as PCBs
(24,26) can be much higher than serum
levels (25,27), and many ofthese chemicals
persist for years in fatty tissues ofthe body
such as the liver, breast, testes, ovaries, and
brain. In sharp contrast to the very long
biological half-lives of most xenobiotics,
our studies (Figure 3) and others (29,31)
demonstrate that phytoestrogens such as
those found abundantly in soy foods have
very short biological half-lives and are inac-
tivated, metabolized, or eliminated within
hours after consumption.
Our studies have also revealed that
xenoestrogens such as DDT can have very
different effects on cell proliferation and
estrogen-regulated end products than estra-
diol or phytoestrogens such as genistein.
For example, estradiol and genistein at
concentrations that half-saturated ER were
equipotent estrogen agonists; they both
induced several well-characterized estro-
gen-regulated proteins (pS2 and PR),
downregulated ER, and stimulated cell
proliferation (Table 3, Figure 2). In con-
trast, DDT did not stimulate the synthesis
of the estrogen-regulated proteins despite
its ability to stimulate cell proliferation
(Table 3). Moreover, DDT differed from
genistein in its effects on cell proliferation
over a broad concentration range. Genistein
demonstrated a biphasic effect on cell
proliferation, stimulating proliferation up
to 1 pM concentration and abruptly
inhibiting proliferation at 10 to 20 pM.
In contrast, DDT persistently stimulated
cell proliferation over the same dose
range. Equol, which is structurally very
similar to genistein (7,12), does not pos-
sess the same growth inhibitory properties
at the high (10-20 pM) concentration.
We previously speculated that structural
features endow genistein with both
relatively potent estrogenic and growth
inhibitory properties that are unique
among the flavonoids (12).
Immunocytochemical staining of
formalin-fixed cells with a pS2-specific
antibody confirmed that only those com-
pounds that induced pS2 in the growth
media increased specific intracellular cyto-
plasmic pS2 antibody staining in MCF-7
cells (Table 3). Nearly all of the estrogens
(excepting equol) that increased both the
intracellular cytoplasmic and extracellular
(growth media) levels ofpS2 also increased
specific nuclear staining for PR, consistent
with the notion that both ofthese proteins
are estrogen-regulated. Most ofthe chemi-
cals tested that downregulated ER also
induced pS2 and PR, as would be expected
for a pure estrogen agonist such as estra-
diol. However, two of the estrogens that
downregulated ER (DDT and quercetin)
did not induce pS2 or PR, indicating a
divergence in the molecular pathways regu-
lating cell proliferation and estrogen
end-production induction.
Although our in vitro tests would
predict that the impact ofxenoestrogens on
estrogen target tissues would be trivial rela-
tive to phytoestrogens, it is important to
recognize that some petrochemicals perturb
endocrine pathways by disrupting other
hormone receptor systems or by modifying
the metabolic disposition of steroid hor-
mones. For example, xenobiotics such as
PCBs and DDE have antiandrogen activity
(32,33). Other xenobiotics such as TCDD
indirectly affect estrogen action by down-
regulating ER, thus acting as an anti-
estrogen (4,5). We (Table 2) and other
investigators (4,5) have found that TCDD
does not bind directly to ER. However, it
does bind to arylhydrocarbon receptor and
induces cytochrome P450 enzymes that
enhance estradiol metabolism (4,5). Many
ofthe xenobiotics have similar actions on
estradiol metabolism (1,34-36), and
therefore could affect the formation of
highly reactive forms ofendogenous estro-
gens that could potentially damage cells,
leading to mutations and eventually to
cancer. For example, hydrocarbon-induced
16a-hydroxyestrone (34) covalently binds
to ER, and estrogen-3,4-quinone, a by-
product of estrogen metabolism, binds
DNA and has been shown to be carcino-
genic in animal models (36).
Another weakness of using in vitro
models to predict the impact ofxenoestro-
gens in vivo is that these model systems do
not take into account how bioaccumulation
ofxenobiotics in hormone-synthesizing
organs (adrenals, ovaries, testes, thyroid)
might alter the ability of those organs to
manufacture endogenous hormones (e.g.,
estradiol, progesterone, testosterone, corti-
sol, dehydroepiandosterone, thyroxine).
Epidemiologic and clinical studies have
closelylinked imbalanced hormone produc-
tion to reproductive dysfunctions, cancers
(breast, uterus, and prostate), premenstrual
syndrome, menopausal symptoms, and
numerous other diseases in humans (heart
disease, osteoporosis, Alzheimer's, immune
dysfunction) (17,37-42).
Experiments on nonhuman primates
have demonstrated that petrochemical pol-
lutants can have a profound impact on
hormone-synthesizing organs (1,2,43,44).
For example, hexachlorobenzene (HCB)
has been shown to suppress luteal proges-
terone synthesis in cynomolgus monkeys
(43). We and other investigators (9) have
not found that HCB binds to ER (Table
1), which would categorize it as a potential
endocrine disruptor but not xenoestrogen.
HCB has also been found in human
serum, fat, and ovarian follicular fluid ofin
vitro fertilization patients, and therefore
could potentially suppress ovarian proges-
terone synthesis in humans. Interestingly,
the stable isomer oflindane, BHCH, was
recently shown to induce estrogenlike
effects through estrogen responsive genes
without apparent binding to ERs (45). We
also found that BHCH does not bind estro-
gen receptors but did not test it further for
effects on cell proliferation.
Although it is well recognized that
failed production of progesterone by the
corpus luteum during the first trimester of
pregnancy leads to miscarriage (17) and
that progesterone is essential for proper
neuronal development (46), virtually
nothing is known about what effect a more
subtle and persistent suppression ofproges-
terone synthesis by xenobiotics might have
on fetal development or on a woman's
overall health, well-being, and susceptibil-
ity to breast and endometrial cancers.
Lower ovarian progesterone production in
adult women has been associated with
increased bone loss (41,42) and estrogen
dominance (37)-risk factors for osteo-
porosis and cancers of the endometrium
and breast.
Because studies show that xenobiotics
suppress progesterone synthesis in non-
human primates (43), it is tempting to
speculate that reported lower birth weight,
smaller skull circumference, lower intelli-
gence, and serious attention deficit disor-
ders (21,22) in children whose mothers
periodically ate fish highly contaminated
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with PCBs and other xenobiotics might
have resulted from xenobiotic-suppressed
synthesis of progesterone, or some other
vital hormone (e.g., thyroid) essential for
proper neuronal development during gesta-
tion. Lowered ovarian progesterone synthe-
sis during gestation could have significant
impact on a child's intellectual capacity and
overall demeanor. This is supported by a
study showing that children born to women
given progesterone supplementation for
preeclampsia during pregnancy were
remarkably more intellectually advanced
and socially well adapted than normal chil-
dren or children whose mothers had
preeclampsia and did not take progesterone
(47). It remains to be determined if the
bioaccumulation ofxenobiotics in organs
such as the ovaries and testes is partly
responsible for the reported increase in
reproductive failures in animals and humans
(1,2), as well as the alarming increase in
attention deficit disorders in children.
In summary, we find that xenoestro-
gens, phytoestrogens, and mycoestrogens,
relative to the parent estrogen estradiol,
may have very different effects on estrogen-
induced end products and regulation ofcell
proliferation depending on the chemical's
structure and concentration. Our in vitro
results concur with those ofSafe's hypothe-
sis that phytoestrogens, commonly con-
sumed in foods, would block binding of
xenoestrogens to ER in target tissues and
thereby negate any harmful effects of
xenoestrogens. However, this concept is
flawed because it is based solely on in vitro
studies and does not take into consideration
the long half-life, bioaccumulation, and
non-ER-mediated actions ofxenobiotics on
hormone-synthesizing organs in the human
body. Future studies should focus not only
on the direct estrogenic actions ofchemicals
as xenoestrogens, but also on the actions of
the broader array ofxenobiotics that conta-
minate our ecosystem as endocrine disrup-
tors via altered synthesis and metabolism of
natural endogenous hormones. Broad field
studies ofthis sort should be feasible with
simple noninvasive saliva assays for steroid
hormones (17).
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